BioCentury
ARTICLE | Company News

Arc Pharma, University of British Columbia deal

November 4, 2002 8:00 AM UTC

Arc received exclusive worldwide rights to the university’s IP covering a class of compounds to treat surgical adhesions, arthritis and psoriasis. The university will receive milestones, royalties and...